China Oncology ›› 2020, Vol. 30 ›› Issue (6): 475-480.doi: 10.19401/j.cnki.1007-3639.2020.06.011

• Review • Previous Articles    

Current status and controversy of cardio-oncology in breast cancer

YANG Yiqi 1 , WU Hao 1,2 , YIN Yongmei 1,2   

  1. 1.Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; 2. Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
  • Online:2020-06-30 Published:2020-07-16
  • Contact: YIN Yongmei E-mail: ymyin@njmu.edu.cn

Abstract: The most common malignant tumor in women is breast cancer, which is also the main cause of female cancer death. Various treatment methods have improved the survival rate of breast cancer patients, and their cardiotoxicities have gradually attracted people's attention. Recent studies have found that anti-tumor drugs do not significantly increase the mortality of cardiovascular disease in patients. This article reviewed current status and controversy of cardio-oncology in breast cancer to provide thoughts for clinical researchers in this field.

Key words: Breast cancer, Cardio-oncology, Cardiotoxicity, Cardiovascular disease